A phase IV, non-interventional, post-marketing registry study on the use of Tracydal® (tranylcypromine) for the treatment of treatment-resistant depression in the Netherlands First published 16/06/2016 Last updated 27/06/2019 EU PAS number:EUPAS13809 Study Ongoing